These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29546654)

  • 1. The AMPK-activator AICAR in thyroid cancer: effects on CXCL8 secretion and on CXCL8-induced neoplastic cell migration.
    Awwad O; Coperchini F; Pignatti P; Denegri M; Massara S; Croce L; Di Buduo CA; Abbonante V; Balduini A; Chiovato L; Rotondi M
    J Endocrinol Invest; 2018 Nov; 41(11):1275-1282. PubMed ID: 29546654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
    Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
    Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal human thyroid cells, BCPAP, and TPC-1 thyroid tumor cell lines display different profile in both basal and TNF-α-induced CXCL8 secretion.
    Coperchini F; Pignatti P; Leporati P; Carbone A; Croce L; Magri F; Chiovato L; Rotondi M
    Endocrine; 2016 Oct; 54(1):123-128. PubMed ID: 26450713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BRAF-inhibitor PLX4720 inhibits CXCL8 secretion in BRAFV600E mutated and normal thyroid cells: a further anti-cancer effect of BRAF-inhibitors.
    Coperchini F; Croce L; Denegri M; Awwad O; Ngnitejeu ST; Muzza M; Capelli V; Latrofa F; Persani L; Chiovato L; Rotondi M
    Sci Rep; 2019 Mar; 9(1):4390. PubMed ID: 30867499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Interferon-γ on the Basal and the TNFα-Stimulated Secretion of CXCL8 in Thyroid Cancer Cell Lines Bearing Either the RET/PTC Rearrangement Or the BRAF V600e Mutation.
    Rotondi M; Coperchini F; Awwad O; Pignatti P; Di Buduo CA; Abbonante V; Magri F; Balduini A; Chiovato L
    Mediators Inflamm; 2016; 2016():8512417. PubMed ID: 27555670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin reverts the secretion of CXCL8 induced by TNF-α in primary cultures of human thyroid cells: an additional indirect anti-tumor effect of the drug.
    Rotondi M; Coperchini F; Pignatti P; Magri F; Chiovato L
    J Clin Endocrinol Metab; 2015 Mar; 100(3):E427-32. PubMed ID: 25590211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-α increases the membrane expression of the chemokine receptor CCR6 in thyroid tumor cells, but not in normal thyrocytes: potential role in the metastatic spread of thyroid cancer.
    Coperchini F; Pignatti P; Carbone A; Bongianino R; Di Buduo CA; Leporati P; Croce L; Magri F; Balduini A; Chiovato L; Rotondi M
    Tumour Biol; 2016 Apr; 37(4):5569-75. PubMed ID: 26577851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canagliflozin reduces thyroid cancer cells migration in vitro by inhibiting CXCL8 and CCL2: An additional anti-tumor effect of the drug.
    Coperchini F; Greco A; Croce L; Pignatti P; Muzza M; Petrosino E; Teliti M; Magri F; Rotondi M
    Biomed Pharmacother; 2024 Jan; 170():115974. PubMed ID: 38056240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective anti-CXCR2 receptor blockade by AZD5069 inhibits CXCL8-mediated pro-tumorigenic activity in human thyroid cancer cells in vitro.
    Coperchini F; Greco A; Petrosino E; Croce L; Teliti M; Marchesi N; Pascale A; Calì B; Pignatti P; Magri F; Uddin M; Rotondi M
    J Endocrinol Invest; 2024 Jun; ():. PubMed ID: 38900374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D Reduces Thyroid Cancer Cells Migration Independently From the Modulation of CCL2 and CXCL8 Chemokines Secretion.
    Coperchini F; Greco A; Croce L; Petrosino E; Grillini B; Magri F; Chiovato L; Rotondi M
    Front Endocrinol (Lausanne); 2022; 13():876397. PubMed ID: 35498406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of the BRAF V600E mutation in thyroid cancer cell lines on the anticancer effects of 5-aminoimidazole-4-carboxamide-ribonucleoside.
    Choi HJ; Kim TY; Chung N; Yim JH; Kim WG; Kim JA; Kim WB; Shong YK
    J Endocrinol; 2011 Oct; 211(1):79-85. PubMed ID: 21795305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-cancer effects of phenformin in thyroid cancer cell lines and in normal thyrocytes.
    Coperchini F; Croce L; Denegri M; Awwad O; Ngnitejeu ST; Magri F; Chiovato L; Rotondi M
    Oncotarget; 2019 Nov; 10(60):6432-6443. PubMed ID: 31741708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AICAR Attenuates TNFα-Induced Inappropriate Secretion of Monocyte Chemoattractant Protein-1 and Adiponectin in 3T3-L1 Adipocytes.
    Nagahara K; Dobashi K; Ishikawa T; Nakano Y; Abe Y; Tanaka D; Itabashi K
    J Atheroscler Thromb; 2016 Dec; 23(12):1345-1354. PubMed ID: 27170207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of S-adenosylhomocysteine hydrolase in inhibition of TNF-alpha- and IL-1beta-induced expression of inflammatory mediators by AICAR in RPE cells.
    Qin S; Ni M; De Vries GW
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1274-81. PubMed ID: 18326758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of Nifuroxazide on Proliferation, Migration, and Invasion of Thyroid Papillary Carcinoma Cells].
    Hu Y; Liang LB; Zhang Q; Lan F; Lin K; He H; Li SQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Jan; 50(1):48-54. PubMed ID: 31037904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AICAR Induces Apoptosis and Inhibits Migration and Invasion in Prostate Cancer Cells Through an AMPK/mTOR-Dependent Pathway.
    Su CC; Hsieh KL; Liu PL; Yeh HC; Huang SP; Fang SH; Cheng WC; Huang KH; Chiu FY; Lin IL; Huang MY; Li CY
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-γ and tumor necrosis factor-α sustain secretion of specific CXC chemokines in human thyrocytes: a first step toward a differentiation between autoimmune and tumor-related inflammation?
    Rotondi M; Coperchini F; Pignatti P; Sideri R; Groppelli G; Leporati P; La Manna L; Magri F; Mariotti S; Chiovato L
    J Clin Endocrinol Metab; 2013 Jan; 98(1):308-13. PubMed ID: 23118425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory activities of fenoterol through β-arrestin-2 and inhibition of AMPK and NF-κB activation in AICAR-induced THP-1 cells.
    Wang W; Chen J; Li XG; Xu J
    Biomed Pharmacother; 2016 Dec; 84():185-190. PubMed ID: 27657826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I and type II interferons inhibit both basal and tumor necrosis factor-α-induced CXCL8 secretion in primary cultures of human thyrocytes.
    Rotondi M; Coperchini F; Sideri R; Groppelli G; de Martinis L; Villani L; Pignatti P; Magri F; Chiovato L
    J Interferon Cytokine Res; 2013 Sep; 33(9):508-13. PubMed ID: 23675779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PFOA, PFHxA and C6O4 differently modulate the expression of CXCL8 in normal thyroid cells and in thyroid cancer cell lines.
    Coperchini F; De Marco G; Croce L; Denegri M; Greco A; Magri F; Tonacchera M; Imbriani M; Rotondi M; Chiovato L
    Environ Sci Pollut Res Int; 2023 May; 30(23):63522-63534. PubMed ID: 37052835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.